Pharming Group Nv Stock Alpha and Beta Analysis
| PHAR Stock | USD 7.65 0.12 1.59% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pharming Group NV. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pharming Group over a specified time horizon. Remember, high Pharming Group's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pharming Group's market risk premium analysis include:
Beta (0.46) | Alpha 0.0183 | Risk 3.14 | Sharpe Ratio 0.0275 | Expected Return 0.0864 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pharming |
Pharming Group Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pharming Group market risk premium is the additional return an investor will receive from holding Pharming Group long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pharming Group. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pharming Group's performance over market.| α | 0.02 | β | -0.46 |
Pharming Group expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pharming Group's Buy-and-hold return. Our buy-and-hold chart shows how Pharming Group performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Pharming Group Market Price Analysis
Market price analysis indicators help investors to evaluate how Pharming Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharming Group shares will generate the highest return on investment. By understating and applying Pharming Group stock market price indicators, traders can identify Pharming Group position entry and exit signals to maximize returns.
Pharming Group Return and Market Media
The median price of Pharming Group for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 8.04 with a coefficient of variation of 6.6. The daily time series for the period is distributed with a sample standard deviation of 0.53, arithmetic mean of 8.09, and mean deviation of 0.45. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Pharming Group to participate in September investor conferences | 09/04/2024 |
2 | Pharming Groups Buy Rating Reaffirmed at HC Wainwright | 09/30/2024 |
3 | Pharming Group Shares Down 3.9 percent Heres What Happened | 10/11/2024 |
4 | Head-To-Head Contrast Pharming Group versus AstraZeneca | 10/17/2024 |
5 | Pharming Group to participate in November investor conference | 11/05/2024 |
About Pharming Group Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pharming or other stocks. Alpha measures the amount that position in Pharming Group NV has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 3.93 | 2.89 | 1.74 | 2.96 | Days Of Inventory On Hand | 493.38 | 879.68 | 821.73 | 780.64 |
Pharming Group Upcoming Company Events
As portrayed in its financial statements, the presentation of Pharming Group's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pharming Group's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pharming Group's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pharming Group. Please utilize our Beneish M Score to check the likelihood of Pharming Group's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Pharming Group
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.